
Personalis PSNL
€ 8.08
5.26%
Quartalsbericht 2026-Q1
hinzugefügt 07.05.2026
Personalis P/E 2011-2026 | PSNL
P/E Jährlich Personalis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.3 | -3.12 | -0.965 | -1.26 | -7.06 | -25.7 | -8.26 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.965 | -25.7 | -7.38 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
34.7 | $ 115.73 | 0.58 % | $ 35.2 B | ||
|
Celcuity
CELC
|
-30.3 | $ 135.2 | 0.7 % | $ 6.32 B | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 7.56 | -17.01 % | $ 10.1 M | ||
|
Castle Biosciences
CSTL
|
-19.5 | $ 21.16 | 7.44 % | $ 613 M | ||
|
Aspira Women's Health
AWH
|
-0.101 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0644 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
-8.7 | $ 17.94 | 1.53 % | $ 552 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-32.3 | $ 125.96 | 5.09 % | $ 15.8 B | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 22.21 | 3.09 % | $ 1.18 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 1.8 | - | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 118.07 | 3.71 % | $ 9.74 B | ||
|
Illumina
ILMN
|
-13.4 | $ 150.57 | 3.68 % | $ 23.9 B | ||
|
Global Cord Blood Corporation
CO
|
0.606 | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 99.25 | -0.81 % | $ 6.7 B | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-18.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 093.55 | -0.71 % | $ 22.5 B | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 163.72 | 4.58 % | $ 8.11 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
NeoGenomics
NEO
|
-13.7 | $ 9.54 | 2.86 % | $ 1.22 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 428.66 | -0.1 % | $ 12.4 B | ||
|
National Research Corporation
NRC
|
27.2 | $ 19.07 | 0.16 % | $ 427 M | ||
|
Natera
NTRA
|
-9.69 | $ 203.12 | 1.1 % | $ 20 B | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 3.92 | 1.69 % | $ 363 M | ||
|
Koninklijke Philips N.V.
PHG
|
33.8 | $ 26.62 | -1.24 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 6.34 | -1.4 % | $ 265 M | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 64.58 | -0.45 % | $ 3.86 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.46 | -0.4 % | $ 5.65 M | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 258.34 | -0.03 % | $ 21.5 B | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | $ 453.73 | 1.22 % | $ 171 B | ||
|
Waters Corporation
WAT
|
30.6 | $ 343.65 | 1.47 % | $ 20.5 B | ||
|
Trinity Biotech plc
TRIB
|
-6.21 | $ 0.68 | 5.27 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 9.29 | 1.64 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 194.25 | 0.69 % | $ 21.6 B |